Current Status of Diagnostic Cytology

Progress in science is often promoted by a new method. Diagnostic cytology, however, developed slowly over a whole century, mainly in differentiating malignant from benign cells from various tissues. The decisive step in this development was the intensive investigation of one local­ ization by Papan...

Full description

Bibliographic Details
Other Authors: Pfitzer, Peter (Editor), Grundmann, E. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1993, 1993
Edition:1st ed. 1993
Series:Recent Results in Cancer Research
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03614nmm a2200313 u 4500
001 EB000677183
003 EBX01000000000000000530265
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9783642849510 
100 1 |a Pfitzer, Peter  |e [editor] 
245 0 0 |a Current Status of Diagnostic Cytology  |h Elektronische Ressource  |c edited by Peter Pfitzer, E. Grundmann 
250 |a 1st ed. 1993 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 1993, 1993 
300 |a XI, 162 p. 24 illus., 11 illus. in color  |b online resource 
505 0 |a Current Status of Diagnostic Cytology -- Current Status of Diagnostic Cytology in Germany -- I. New Methods in Diagnostic Cytology -- Tumor Biology in Diagnostic Cytology: DNA Cytometry in Carcinomas of the Bladder and Prostate -- Cytodiagnosis of Viral Infections -- Cytology of Viral Infections in Gynecologic Smears -- Immunocytochemistry in Diagnostic Cytology -- Nucleolar Organizer Region Associated Proteins: A Diagnostic Tool in Cytology? -- Automation in Cytology -- II. State of the Art of Old Methods -- Sampling and Processing in Gynecological Cytology -- The Munich Nomenclature -- The Bethesda System: The European Perspective -- III. Benign Changes in Cytology -- Fluorescence Microscopy for Pneumocystis carinii -- IV. Quality Control -- Quality Control in Cytology -- V. Who Is a Cytologist? -- Who Is a Medical Cytologist? -- Cytology Training in the European Community: European Community Training Programme in Cervical Cancer Screening -- The Austrian Regulation -- The Swiss Regulation for the Specializations of Cytopathology and Gynecocytology -- Diagnostic Cytology in the United States -- Cytotechnologists in Germany -- Outlook for Diagnostic Cytology in Germany 
653 |a Cell Biology 
653 |a Cytology 
653 |a Oncology 
653 |a Pathology 
700 1 |a Grundmann, E.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
490 0 |a Recent Results in Cancer Research 
028 5 0 |a 10.1007/978-3-642-84951-0 
856 4 0 |u https://doi.org/10.1007/978-3-642-84951-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.994 
520 |a Progress in science is often promoted by a new method. Diagnostic cytology, however, developed slowly over a whole century, mainly in differentiating malignant from benign cells from various tissues. The decisive step in this development was the intensive investigation of one local­ ization by Papanicolaou: The application of cytology for screening in the field of gynecologic oncology made it an acknowledged technique. Consequently, materials inves­ tigated before were tested again on a larger scale and new ones were included into the program. The possibility of a wide-range application of this diag­ nostic method, which carries a low risk for the patient and is low in cost, attracted the specialists of many fields. One of the problems which has resulted is the coordination of training and quality assurance for a large group of people from different fields and with different interests and whose experience in morphology varies. In this volume general problems of cytology are dis­ cussed, as is the question "who is a medical cytologist?" Education and training are the topics of the contributions by Coleman, Holzner, Jenny, Koss and Muller, cover­ ing the situation in the European Community, Germany, Austria, Switzerland, and the USA. A special contribu­ tion by Lange concerns the situation of cytotechnologists, paramedicals important for cytologic screening programs